anti-ADAM Metallopeptidase with Thrombospondin Type 1 Motif, 7 (ADAMTS7) Antibodies

Mouse (Murine) ADAM Metallopeptidase with Thrombospondin Type 1 Motif, 7 (ADAMTS7) interaction partners

1. Therefore, these data provided the in vivo evidence, suggesting that ADAMTS-7 may play an important role in the pathogenesis of inflammatory arthritis.

2. Mice lacking Adamts7, Ldlr, Apoe had less lesion formation in aortas and aortic roots vs controls and less neointimal formation after femoral wire injury. Adamts7 expression was induced by injury and hyperlipidemia.

3. Adamts-7 deficiency substantially ameliorated neointima formation in mice at days 14 and 28 after injury. ADAMTS-7 inhibited both endothelial cell proliferation and migration.

4. ADAMTS-7 and TNF-alpha (show TNF Antibodies) form a positive feedback loop in the regulation of cartilage degradation and osteoarthritis progression.

5. ADAMTS7B has a domain organization with a total of eight thrombospondin type 1 repeats in its ancillary domain. Of these, seven are arranged in two distinct clusters that are separated by a mucin (show SLC13A2 Antibodies) domain

6. Findings demonstrate that ADAMTS-7, a direct target of PTHrP signaling, negatively regulates endochondral bone formation by associating with and inactivating GEP (show GRN Antibodies) chondrogenic growth factor.

Human ADAM Metallopeptidase with Thrombospondin Type 1 Motif, 7 (ADAMTS7) interaction partners

1. The native overfunctional ADAMTS7 allele (A) may accelerate VSMC migration and lead to neointimal thickening, atherosclerosis progression and acute plaque events.

2. miR (show MLXIP Antibodies)-105/Runx2 (show RUNX2 Antibodies) axis mediates FGF2 (show FGF2 Antibodies)-induced ADAMTS (show ADAMTS13 Antibodies) expression in osteoarthritis cartilage.

3. Allelic variation that associates with reduced ADAMTS7 expression confers stronger coronary heart disease protection in never-smokers than in ever-smokers.

4. During inflammatory conditions, AP-1 (show FOSB Antibodies) and Sp1 (show PSG1 Antibodies) sustained the expression of ADAMTS7, and ADAMTS7 sustained the expression of catabolic genes in nucleus pulposus cells

5. ADAMTS7 and LPA single nucleotide polymorphisms are related to a 24-h ambulatory systolic-diastolic pressure regression index.

6. Expression of miR (show MLXIP Antibodies)-26a and miR (show MLXIP Antibodies)-29a was significantly down regulated in leukoplakia and cancer tissues but up regulated in lichen planus tissues. Expression of target genes such as, ADAMTS7, ATP1B1 (show ATP1B1 Antibodies), COL4A2 (show COL4a2 Antibodies), CPEB3 (show CPEB3 Antibodies), CDK6 (show CDK6 Antibodies), DNMT3a (show DNMT3A Antibodies) and PI3KR1 was significantly down regulated in at least two of three disease types with respect to normal tissues.

7. Our results indicate the presence of ADAMTS-7 in human NP cells and imply its potential role in disc degeneration.

8. The main contribution of this study is the proposal of a pharmacophore for ADAMTS7.

9. The significant associations observed between this coding variant in ADAMTS7 and the risk of CAD (show CAD Antibodies) development.

10. Logistic regression analysis indicated that the association between ADAMTS-7 and heart failure after AMI (show CFD Antibodies) was independent from traditional cardiovascular risk factors and other biomarkers